Drug-Eluting Stents in Percutaneous Coronary Intervention: A Benefit-Risk Assessment

Author： Byrne Robert A.   Sarafoff Nikolaus   Kastrati Adnan   Schömig Albert  

Publisher： Adis International

ISSN： 0114-5916

Source： Drug Safety, Vol.32, Iss.9, 2009-09, pp. : 749-770

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Use of Antiplatelet Therapy after Percutaneous Coronary Intervention with Bare-Metal Stents and Different Types of Drug-Eluting Stents

By  

Current Clinical Pharmacology, Vol. 8, Iss. 1, 2013-02 ,pp. : 59-66

Bentham Science Publishers

Access to resources Recommend Favorite

Percutaneous coronary intervention with drug-eluting stents or coronary artery bypass surgery in subjects with type 2 diabetes

By Doggrell Sheila A  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 9, 2013-06 ,pp. : 1269-1273

Informa Healthcare

Access to resources Recommend Favorite

Drug-eluting stents beneficial for high-risk patients

By  

Inpharma, Vol. 1, Iss. 1609, 2007-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Drug-Eluting Stents

By  

Heart Drug, Vol. 3, Iss. 4, 2004-02 ,pp. : 203-213

Karger

Access to resources Recommend Favorite

Drug Eluting Coronary Artery Stents

By  

Current Drug Delivery, Vol. 7, Iss. 5, 2010-12 ,pp. : 421-427

Bentham Science Publishers

Access to resources Recommend Favorite